The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Many cases of mild to moderate psoriasis may be treatable with topical medication. The effectiveness of these treatments varies from person to person, depending on the severity of their psoriasis ...

The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron) for the treatment of overactive ... on pharmacological therapy for benign prostatic hyperplasia (BPH).

making them widely utilized in the treatment of BPH (82). Currently, a diverse array of oral Chinese patent medicines is employed for the management of BPH. Nevertheless, there is an absence of ...

New trials, including Focal One robotic HIFU and ProVee System, are exploring novel approaches to BPH treatment, expanding therapeutic options. Real-world data support the safety and efficacy of ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Roach: I was diagnosed with an enlarged prostate two months ago ... What is true and what the urologist may really mean is that these drugs work very slowly. You’ll get about half the benefit ...

Roach: I was diagnosed with an enlarged prostate two months ago ... What is true and what the urologist may really mean is that these drugs work very slowly. You’ll get about half the benefit ...

Anticholinergic medications are the mainstay of urinary incontinence management. Other prescription treatment options include Botox (onabotulinumtoxinA), beta-3 adrenergic agonists, estrogen, ...